Trial Profile
A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma(JCOG1605, JCOG-PACS)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2018
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Haemangiosarcoma
- Focus Therapeutic Use
- 26 Feb 2018 New trial record